About Dr. Reuben Farris CV
Education
Undergraduate: University of Mississippi, Oxford, MS, B.S. degree 5/75
Graduate: University of Mississippi, Jackson, MS, M.D. degree 5/79
Post-Graduate:
Naval Hospital, Oakland, CA, Basic Medicine Internship
Naval Hospital, San Diego, CA, Anesthesia Residency
July 1980 thru November 1981 (not completed)
More about Dr. Reuben Farris
Clinical Activities
General Medical Officer, Naval Medical Clinic
Marine Corps Recruit Depot, San Diego
November 1981 thru August 1984
Duties included direct patient care, supervising Recruit Sick Call and Emergency Room; coordinating 4 physicians, 3 physician assistants, 2 optometrists, 1 podiatrist, and 15-20 corpsmen; with an average daily load of 350-400 patients. Duties also included developing and coordinating the Continuing Medical Education programs for clinic medical staff comprised of a weekly lecture series.
Lead Physician, Readicare Center, Chula Vista
October 1984 thru September 1988
Duties included patient care; physician evaluation, orientation, and scheduling; supervising physical therapy; Quality Assurance; Occupational Medicine programs.
Private Practice, Family Medicine
Southern California Health Providers Medical Group
September 1988 to present
Chief-of–Staff Equivalent
Scripps Mercy Hospital, Chula Vista
2009-2010
Credentials Cmte Chair
Scripps Mercy Hospital, Chula Vista
2011-2012
President, San Diego Physicians Medical Group
2011-present
Hospital Affiliations
Scripps Memorial Hospital–Chula Vista (Active Staff)
Sharp Community Hospital of Chula Vista (Affiliate Staff)
Professional Organizations
American Academy of Family Physicians
San Diego Academy of Family Physicians
California Medical Association
San Diego County Medical Society
Research Experience
Sub- Investigator: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C):
Sub-Investigator: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects with Early Decompensated Liver Cirrhosis
Quick Links
Volunteer Now
Learn More
Keep
In Touch
MAP
Powered by: 